BioSpace News Archive

Phil, Inc. announces partnership with Impel NeuroPharma, Inc. (NASDAQ: IMPL) in support of Trudhesa™ (dihydroergotamine mesylate) nasal spray (0.725 mg per spray) to provide technology-powered patient support and distribution services through Phil’s proprietary workflow to enhance the patient’s access to therapy.

Hangzhou Chance Pharmaceuticals, a clinical-stage biotechnology company focusing on discovering, developing, and commercializing transformative inhalation therapies for the world’s most debilitating diseases, announced that it has appointed Guobao Zhao as Senior Vice President responsible for business development and corporate strategy.

Acurx Pharmaceuticals, Inc. announced today that management will participate in the A.G.P. Biotech and Specialty Pharma Conference on October 13 2021.

Immunexpress, Inc. announced a presentation, titled “Comparison of lactate, procalcitonin and a gene signature assay alone or in combination to differentiate sepsis from non-infectious systemic inflammation in ICU patients” (ID#994), which details the superior performance of SeptiCyte® RAPID in differentiating sepsis from non-infectious inflammatory responses at the 2021 IDWeek Conference, taking place virtually from Sept. 29-Oct. 3, 2021.

Phosplatin Therapeutics Inc. today announced the appointment of Elizabeth Tallett to the company’s Board of Directors.

AgNovos Healthcare, LLC and Asahi Kasei Pharma Corporation announced that the companies have entered into an exclusive option agreement for the commercialization of AgNovos’ AGN1 LOEP Hip Kit in Japan.

Syros Pharmaceuticals today announced that the first patient has been dosed in the dose confirmation study of SY-2101, a novel oral form of arsenic trioxide (ATO).

Caretaker Medical, a pioneer in wireless “beat by beat” continuous, non-invasive, advanced patient monitoring, today announced U.S. Food and Drug Administration (FDA) clearance of the company’s next-generation VitalStream™ wireless blood pressure and hemodynamic monitoring platform.

Asensus Surgical, Inc. today announced Sapporo Medical University Hospital, located in Hokkaido, Japan, has entered into an agreement to lease and utilize a Senhance® Surgical System.

PureTech Founded Entity Akili Announces Topline Results from Shionogi Phase 2 Study in Japan